SCHEMBL60709

SCHEMBL60709

COC(=O)c1cccc(N)c1C(=O)OC

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.69
HSD17B10 Q99714 4/20 0.69
CFTR P13569 2/20 0.69
CA1 P00915 2/20 0.53
CA2 P00918 2/20 0.53
CA9 Q16790 2/20 0.53
CA12 O43570 1/20 0.53
CA7 P43166 1/20 0.53
CA14 Q9ULX7 1/20 0.53
KDM4E B2RXH2 7/20 0.50
TSHR P16473 2/20 0.50
LMNA P02545 2/20 0.50
GAA P10253 5/20 0.49
MAPT P10636 4/20 0.49
HPGD P15428 3/20 0.49
GLA P06280 2/20 0.49
ATM Q13315 2/20 0.49
CASP1 P29466 1/20 0.49
CASP7 P55210 1/20 0.49
CA5A P35218 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30342070 1.00 ALDH1A1 (0.69) ALDH1A1HSD17B10CFTRCA1CA2
SCHEMBL8892028 0.89 ALDH1A1 (0.59) ALDH1A1HSD17B10CFTRCA1CA2
SCHEMBL2993964 0.89 ALDH1A1 (0.65) ALDH1A1HSD17B10CFTRCA1CA2
SCHEMBL14589543 0.89 ALDH1A1 (0.59) ALDH1A1HSD17B10CFTRCA1CA2
SCHEMBL30216752 0.89 ALDH1A1 (0.65) ALDH1A1HSD17B10CFTRCA1CA2
SCHEMBL14828744 0.89 ALDH1A1 (0.65) ALDH1A1HSD17B10CFTRCA1CA2
SCHEMBL6312035 0.88 CA12 (0.61) ALDH1A1HSD17B10CFTRCA1CA2
SCHEMBL6995362 0.87 ALDH1A1 (0.53) ALDH1A1HSD17B10CFTRCA1CA2
SCHEMBL1666445 0.86 CA1 (0.64) ALDH1A1HSD17B10CFTRCA1CA2
SCHEMBL8547750 0.83 MAPT (0.59) ALDH1A1HSD17B10CFTRCA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 230 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111499531-B Method for preparing dimethyl aminophthalate 扬州工业职业技术学院 2023-04-07 CN claimed
CN-109970568-B Synthesis process of 3-amino dimethyl phthalate 扬州工业职业技术学院 2022-09-02 CN claimed
CN-216172207-U Hydrogenation reaction kettle for preparing 3-amino-dimethyl phthalate 山东友帮生化科技有限公司 2022-04-05 CN claimed
CN-110746400-A Androgen receptor targeted fluorescent probe and preparation method thereof 郑州大学 2020-02-04 CN claimed
CN-110483304-A A kind of preparation method of 3- aminophthalic acid dimethyl ester YANGZHOU POLYTECHNIC INST 2019-11-22 CN claimed
CN-109970568-A A kind of green synthesis process of 3- aminophthalic acid dimethyl ester 扬州工业职业技术学院 2019-07-05 CN claimed
US-10106550-B2 Aza-phenalene-3-ketone derivative, preparation method thereof, and its application as PARP inhibitor SUZHOU KANGRUN PHARMACEUTICALS INC. (CN) 2018-10-23 US claimed
US-20180134722-A1 AZA-PHENALENE-3-KETONE DERIVATIVE, PREPARATION METHOD THEREOF, AND ITS APPLICATION AS PARP INHIBITOR SUZHOU KANGRUN PHARMACEUTICALS INC. (CN) 2018-05-17 US claimed
EP-3305793-A1 DERIVATIVE OF NITROGEN-DOPED PHENALENE-3-KETONE, PREPARATION METHOD THEREFOR AND APPLICATION OF DERIVATIVE USED AS PARP INHIBITOR Suzhou Kangrun Pharmaceuticals, Inc. (CN) 2018-04-11 EP claimed
CN-104945406-B Derivative, its preparation method and its application as PARP inhibitor of that non-ketone of alkene 3 of azepine 苏州康润医药有限公司 2017-10-10 CN claimed
CN-106631844-A Preparation method of dimethyl 3-aminophthalate 山东友帮生化科技有限公司 2017-05-10 CN claimed
CN-104945406-A Aza-phenalene-3-ketone derivative, preparation method thereof and application of aza-phenalene-3-ketone derivative as PARP inhibitor SUZHOU KANGRUN PHARMACEUTICALS INC 2015-09-30 CN claimed
WO-1997047589-A1 AMINOPHTHALIC ACID DERIVATIVES BAYER AKTIENGESELLSCHAFT (DE) 1997-12-18 WO claimed
CN-120040355-A Synthesis process and application of luminol monosodium salt precursor for chemiluminescent substrate liquid 浙江鑫科医疗科技有限公司 2025-05-27 CN disclosed
CN-119753869-A Shape memory prestress anchor net material and preparation method thereof 中煤科工开采研究院有限公司 2025-04-04 CN disclosed
CN-116368131-B Novel Smad3 protein degradation agent and application thereof 和径医药科技(上海)有限公司 2024-09-20 CN disclosed
EP-0471756-A1 SACCHARIN DERIVATIVES USEFUL AS PROTEOLYTIC ENZYME INHIBITORS AND PREPARATION THEREOF. STERLING WINTHROP INC (US) 1992-02-26 EP disclosed
EP-0101330-B1 2-QUINOLONE DERIVATIVES NIPPON SHINYAKU COMPANY, LIMITED (JP) 1988-08-24 EP disclosed
US-4526894-A Antiinflammatory agents NIPPON SHINYAKU CO. LTD. (JP) 1985-07-02 US disclosed
EP-0101330-A2 2-Quinolone derivatives NIPPON SHINYAKU COMPANY, LIMITED (JP) 1984-02-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180134722-A1 AZA-PHENALENE-3-KETONE DERIVATIVE, PREPARATION METHOD THEREOF, AND ITS APPLICATION AS PARP INHIBITOR PARP1, PARP11, PARP3 ALDH1A1 812/4885HSD17B10 583/4885CFTR 4629/4885
US-10106550-B2 Aza-phenalene-3-ketone derivative, preparation method thereof, and its application as PARP inhibitor PARP1, PARP11, PARP3 ALDH1A1 812/4885HSD17B10 583/4885CFTR 4629/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.